Fret not people. The stagnant share price will be only flush out the impatient & weak.
We haven't been added into 2 GLOBAL Covid trials fro nothing. WE have a product for ARDS with an unmet need during the current pandemic aswell as future generations to come. Add into equation Clevegen, where treatment reduced tumour size by 44% when all other treatments failed, then id safely say were at the forefront with both our medicines.
We know very little about the secret weapon. An RNS with further info would certainly whet the appetite even more.
Wouldn’t even worry about it. The swedish pension fund don’t investment several million euros for nothing. Mark stated significant shareholder value 8-12 months time. Well that was on April 22nd. So that window is now 7-11 months!